Bhagiradha Chemicals & Industries Ltd

Q1 FY27Fertilizers & Agrochemicals

Bhagiradha Chemicals & Industries Ltd Q1 FY27 Results & Presentation Highlights: Revenue, Margins & Order Book

Q1 FY27 investor presentation: what the company reported on revenue, margins and projects.

Price₹246

Market cap₹3.2K Cr

P/E116.3

Updated25 Sept 2026

Read4 min read

Based on Bhagiradha Chemicals & Industries Ltd's Q1 FY27 investor presentation. The company has not published an earnings-call transcript for this quarter, so figures here are what the presentation reports, not management guidance.

The short version

Revenue from Operations for Q1 FY27: Rs. Q1FY27 EBITDA: Rs.

From Bhagiradha Chemicals & Industries Ltd's Q1 FY27 earnings-call transcript · updated 25 Sept 2026.

Revenue & Sales Performance

Revenue from Operations for Q1 FY27: Rs. 195.0 crore
Revenue for Q1 FY26: Rs. 123.8 crore
Year-on-Year (YoY) revenue growth: 58%
Volume increase cited due to better demand, new molecule launches, customer additions, and ramp-up at Bheema Fine Chemicals (Page 5)
Price realizations improved due to better product mix and higher sales of mid- and high-value products
Outlook:
Expect progressive ramp-up at Bheema Fine Chemicals and introduction of additional mid- to high-value molecules to support stronger growth (Page 7)

2 more points management made on revenue & sales performance

Profitability & Margins

- **Q1FY27 EBITDA:** Rs. 30.5 crores, up 240% YoY from Rs. 9.0 crores in Q1FY26 - **Q1FY27 EBITDA Margin:** 15.7%, up 839 bps YoY from 7.3% in Q1FY26 - **Q1FY27 Profit After Tax (PAT):** Rs. 13.3 crores, up 235% YoY from Rs. 4.0 crores in Q1FY26 - **Q1FY27 PAT Margin:** 6.8%, up 362 bps YoY from 3.2% in Q1FY26 **Margin Outlook:** - The presentation states margin improvement driven by better realizations, favorable product mix, and operating leverage.

2 more points management made on profitability & margins

See what Bhagiradha Chemicals & Industries Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Total expansion investment of Rs. 850+ crores under phased program (Page 22).
Equity infusion: ~Rs. 410+ crores; Debt: ~Rs. 460+ crores (Page 22).
Allocation: Land & Building ~Rs. 200 crores; Plant & Machinery ~Rs. 600 crores (Page 22).
Greenfield Capacity Expansion at Karnataka Kadechur facility: 9,002 MT capacity, 2 processing blocks (Page 14).
Bheema Fine Chemicals plant (100% subsidiary) commercialized March 27, 2024, with ~Rs. 450 crores capex done over last two years (Pages 20, 32).
Phases of expansion:
Phase 1A (~Rs. 39 crores) commenced March 2024 (Page 22).
Phase 1B (~Rs. 411 crores) commenced Q3 FY26, ramp-up 12–24 months post-commencement (Page 22).
Phase 2 (~Rs. 400 crores) expected commencement Q2 FY28, ramp-up 12–24 months thereafter (Page 22).

2 more points management made on capital expenditure plans

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

5x potential

1Anya Polytech & Fertilizers Ltd₹180 Cr

Rev 2Mar 1

2Dharmaj Crop₹934 Cr

Rev 2Mar 2

3₹7.0K Cr

Rev 2Mar 3

4₹5.6K Cr

Rev 2Mar 3

5₹1.3K Cr

Rev 3Mar 1

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The presentation mentions a capital raise history with cumulative promoters’ participation of Rs. 51 crores.
Fundraising includes Preferential Allotment, Right Issue, and Preferential Allotment totaling Rs. 484 crores (Rs. 59 Cr + Rs. 84 Cr + Rs. 341 Cr).
Rs. 341 crores raised through fully subscribed convertible warrants issued preferentially in November 2023.
A term loan allocation is mentioned as part of an Rs. 850+ crores expansion program (~Rs. 460 crores debt and ~Rs. 410+ crores equity).
Conversion of loans amounting to Rs. 367.52 crores into equity in the subsidiary as of May 2025.

2 more points management made on fundraising & capital structure

See what Bhagiradha Chemicals & Industries Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The investor presentation does not explicitly report any details on order book, order inflow, or pending orders. Specifically: - There is no mention or data related to the size or value of the current order book. - The presentation does not discuss order inflow numbers or trends. - Pending orders or order backlog figures are not provided or referenced anywhere in the document.

- The focus of the presentation is on financial performance, capital raise history, capacity expansion, production, and investment updates. - Key metrics highlighted include revenue, EBITDA, profit, capacity utilization, and capital expenditure but no order-related data. Hence, based solely on the contents of this presentation, no information about order book, order inflow, or pending orders is shared.

2 more points management made on order book & pipeline

Bhagiradha Chemicals & Industries Ltd — Quarterly revenue & net profit

Revenue Net profit Net loss

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Mar 2026

Reported quarterly figures (₹ Cr). Latest: revenue ₹158 Cr, net profit ₹4 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Bhagiradha Chem.'s management said in earlier quarters

Q4 FY26 earnings call analysis →

Others in Fertilizers & Agrochemicals this season

Advance Agrolife Ltd (Q1 FY27)
Q1 FY27 revenue from operations: ₹3,304 million, a 96% year-on-year (YoY) increase (Page 23, 25, 22). Key investor presentation takeaways from Advance Agrolife
Sumitomo Chemical India Ltd (Q1 FY27)
1,063.3 crore, a 1% year-on-year (YoY) increase from Rs. Key investor presentation takeaways from Sumitomo Chemical India Ltd's Q1 FY27 investor presentation —
Dharmaj Crop (Q1 FY27)
Revenue from Operations for Q1 FY27: ₹3,841 Mn, a 5% increase YoY from ₹3,674 Mn in Q1 FY26. Key investor presentation takeaways from Dharmaj Crop Guard Ltd's Q
M B Agro Prod. (Q1 FY27)
. Key concall takeaways from Madhya Bharat Agro Products Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Coromandel Inter vs F A C T vs UPL

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Bhagiradha Chemicals & Industries Ltd Q1 FY27 results?

Revenue from Operations for Q1 FY27: Rs. Q1FY27 EBITDA: Rs.

What is Bhagiradha Chemicals & Industries Ltd share price analysis?

Bhagiradha Chemicals & Industries Ltd currently shows a neutral. The stock trades at a P/E of 116.3 with a market cap of ₹3,201 Cr. Investors should review the full earnings analysis for detailed insights.

Is Bhagiradha Chemicals & Industries Ltd planning capital expenditure?

Total expansion investment of Rs.

Keep Bhagiradha Chemicals & Industries Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and the company's investor presentation. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.